Ibuprofen Market size to grow from USD 96 million in 2022 to USD 112.3 million by 2028, at a Compound Annual Growth Rate (CAGR) of 2.7% by Valuates Reports

The global ibuprofen market size is estimated to be worth US$ 96 million in 2022 and is projected to reach US$ 112.3 million by 2028 with a CAGR of 2.7% during the forecast period. Key drivers of the ibuprofen market include the expanding pharmaceutical production and increasing prevalence of chronic diseases such as arthritis, kidney disease, cardiovascular diseases, diabetes, etc.

Further, the usage of advanced technologies in drug development is expected to propel the growth of the ibuprofen market in the coming years.

Inquire for sample report: https://reports.valuates.com/request/sample/QYRE-Auto-28E9344/Ibuprofen_Market

Based on type, the USP segment is expected to provide lucrative opportunities for growth in the ibuprofen market share during the forecast period and will hold a share of 65%.

Based on application, the tablet segment is expected to provide lucrative opportunities for growth in the ibuprofen market share and will hold a share of 46%.

Based on region, Asia-pacific will lead on a production basis with China being the largest supplier at a market share of 48% and India at 30%. On the other hand, North America will provide lucrative opportunities for growth based on sales in the ibuprofen market share and will hold a share of 29%. Europe is the second-largest at 26%.

View Full Report: https://reports.valuates.com/reports/QYRE-Auto-28E9344/ibuprofen

Consequence of Covid-19 Pandemic
The authors of this study have enlightened the readers on the rise and effect of the Covid-19 outbreak on the development. They have investigated the changes brought about in the demand/supply side, consumption, supply chain, and sales/manufacturing. The readers will get familiar with the measures that have helped the key players to bring the Ibuprofen market back to the pre-covid levels.

Trends & Prospects
In this segment of the report, the specialists have delved into the key growth opportunities that are likely to emerge. This will aid the key players to simplify complex issues related to business and frame future strategies to compete in this competitive environment. This section will certainly assist the players to boldly position their business.

By Type
➣USP
➣EP

By Application
➣Tablet
➣Capsule
➣Suspension
➣Others

By Region
➣North America
➣United States
➣Canada
➣Asia-Pacific
➣China
➣Japan
➣South Korea
➣India
➣Southeast Asia
➣Australia
➣Rest of Asia-Pacific
➣Europe
➣Germany
➣France
➣U.K.
➣Italy
➣Russia
➣Nordic Countries
➣Rest of Europe
➣Latin America
➣Mexico
➣Brazil
➣Rest of Latin America
➣Middle East & Africa
➣Turkey
➣Saudi Arabia
➣UAE
➣Rest of MEA

List of Key Players
➣Xinhua Pharmaceutical
➣IOLCP
➣Granules Biocause
➣Strides Shasun
➣BASF
➣SI Group
➣Xinhua-Perrigo Pharmaceutical
➣Hisoar

Similar Reports:

Antacid Market: https://reports.valuates.com/reports/QYRE-Auto-21G9536/antacid

Ibuprofen API Market: https://reports.valuates.com/market-reports/QYRE-Auto-12X6333/global-ibuprofen-api-sales

Valuates Reports
sales@valuates.com
For U.S. Toll Free Call +1-(315)-215-3225
For IST Call +91-8040957137
WhatsApp : +91-9945648335

Website: https://reports.valuates.com
Twitter - https://twitter.com/valuatesreports
Linkedin - https://in.linkedin.com/company/valuatesreports
Facebook - https://www.facebook.com/valuatesreports/

Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs.

This release was published on openPR.